SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-22-040369
Filing Date
2022-07-19
Accepted
2022-07-19 17:30:27
Documents
1
Period of Report
2022-07-15

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3779
  Complete submission text file 0001213900-22-040369.txt   5071
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Issuer) CIK: 0000316253 (see all company filings)

IRS No.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
SIC: 8071 Services-Medical Laboratories

Mailing Address 527 MADISON AVE NEW YORK NY 10022
Business Address
Cannon Kara (Reporting) CIK: 0001913009 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-09974 | Film No.: 221092319